tiprankstipranks
Trending News
More News >

Syntara Limited Issues Unquoted Performance Rights

Story Highlights
  • Syntara Limited issues 551,501 performance rights under an employee incentive scheme.
  • The unquoted securities are restricted from transfer, aiming to enhance employee retention and motivation.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Syntara Limited Issues Unquoted Performance Rights

Don’t Miss TipRanks’ Half-Year Sale

An announcement from Pharmaxis Ltd ( (AU:SNT) ) is now available.

Syntara Limited has announced the issuance of 551,501 performance rights as part of an employee incentive scheme. These securities are unquoted and subject to a restriction on transfer until the restriction ends, indicating a strategic move to retain and motivate employees, potentially impacting the company’s operational efficiency and market competitiveness.

The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.25 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.

More about Pharmaxis Ltd

Average Trading Volume: 11,218,662

Technical Sentiment Signal: Sell

Current Market Cap: A$82.87M

Find detailed analytics on SNT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1